Because there is a general paucity of pancreatic NEN cell lines and most studies are limited to BON-1 and QGP-1 cells, we added the primary NEC cell line MS-18, which was recently established by our group and displays a higher basal CXCR4 expression. The gene discussed is CXCR4; the disease is neuroendocrine carcinoma.